(1)
Treatment Interruption of Biological Drugs and Tofacitinib in Rheumatoid Arthritis: A Systematic Review of Case Reports. Braz. J. Pharm. Sci. 2018, 54 (4), e17437. https://doi.org/10.1590/s2175-97902018000417437.